Cardica and Cook Medical enter new collaboration agreement to
develop and commercialize closure device for heart defects.
Cardica, Inc. (Redwood City, CA) and Cook Medical (Bloomington, IN)
entered into an agreement to develop and commercialize a specialized
device designed to close the patent foramen ovale (PFO), a . . .
Bayer CropScience and Monsanto enter long-term business and
license agreements for key enabling technologies agreements creating
Bayer CropScience AG (Monheim, Germany) and Monsanto Company (St.
Louis, MO), two of the leading agro-companies worldwide, entered into a
series of long-term business and licensing agreements . . .
Pieris progresses development of its proprietary biotherapeutics
platform.(Pieris Proteolab)
Pieris AG, (Freising-Weihenstephan, Germany) a bio-pharmaceutical
company developing Anticalins, a novel class of targeted human protein
therapeutics, said that its
proprietary Duocalin . . .
Ruling in favor of Neuralstem leads to stay of Stemcells
lawsuit.
Neuralstem, Inc. (Rockville, MD) said that StemCells, Inc. (Palo
Alto, CA) has consented to a stay of the lawsuit it filed against
Neuralstem in August 2006. The motion also stays . . .
BioVeris completes merger with Roche.(Company overview)
BioVeris Corporation's (Gaithersburg, MD) stockholders voted
to approve Roche's (Basel, Switzerland) acquisition of BioVeris.
The acquisition will allow Roche Diagnostics to expand . . .
United States Patent and Trademark Office rejects Vitrolife
patent claims.
In November 2005, IVFonline.com, LLC (Guilford, CT), among others,
was sued for patent infringement of United States Patent 6,838,235 (the
'235 patent) by Vitrolife, AB (Sweden). In particular, . . .
General public supports breaking drug patents to ensure access to
HIV/AIDS drugs in poorer countries.
In May 2007, Brazil's President Luiz Inacio Lula da Silva took
steps to make an inexpensive generic version of a patented AIDS drug
manufactured by Merck & Co., Inc. (Whitehouse Station, NJ) . . .
Oncolytics Biotech announces issuance of 6th Canadian
patent.
Oncolytics Biotech, Inc. (Calgary, Canada) has been granted
Canadian Patent 2,437,468 entitled "Sensitization of
Chemotherapeutic Agent Resistant Neoplastic Cells with Reovirus."
The claims . . .
Consumer groups file comments supporting United States Patent and
Trademark Office's stem cell patent rejection '.
Two consumer groups have filed comments with the United States
Patent and Trademark Office supporting its rejection of human embryonic
stem cell patent claims asserted by the Wisconsin Alumni . . .
Par Pharmaceutical licenses United States commercialization
rights to antifungal Loramyc.
Par Pharmaceutical Companies, Inc. (Woodcliff Lake, NJ) entered
into an exclusive licensing agreement under which Par will receive
commercialization rights in the United States to . . .
Novavax licenses Wyeth's virus-like particle
technology.
Novavax, Inc. (Rockville, MD) has signed a non-exclusive, worldwide
license agreement with Wyeth , to obtain rights to a patent application
covering virus-like particle (VLP) technology for use in . . .
Macrochem acquires option to license Pexiganan, a novel topical
anti-infective for treatment of diabetic foot infection.
MacroChem Corporation (Wellesley Hills, MA) has signed an exclusive
option to acquire exclusive worldwide license rights for drug uses of
pexiganan, a novel, small peptide anti-infective for . . .
Ciphergen licenses more than 25 patents from Health
Discovery.
Ciphergen Biosystems, Inc. (Fremont, CA) has entered into a license
and settlement agreement with Health Discovery Corporation (Savannah,
GA) pursuant to which it licensed more than 25 patents . . .
Ciphergen receives notice of intent from United States Patent and
Trademark Office for re-Issuance of SELDI mass spectrometry
pa
Ciphergen Biosystems, Inc. (Fremont, CA) received from the United
States Patent and Trademark Office a notice of intent to issue a
Reexamination Certificate of United States Patent 6,734,022, which . . .
Nastech announces issuance of patents for parathyroid hormone
nasal spray for osteoporosis.
Nastech Pharmaceutical Company, Inc. (Bothell, WA) announced the
issuance of two United States patents by the United States Patent and
Trademark Office. The patents relate to the company's . . .
Monogram Biosciences obtains United States patent.
Monogram Biosciences, Inc. (South San Francisco, CA) has patented a
method for identifying whether a compound inhibits entry of a virus into
a cell which comprises: (a) obtaining nucleic acid . . .
Beckman Instruments obtains United States patent.
Beckman Instruments, Inc. (Fullerton, CA) has patented gene for
Streptococcus pyogenes DNase B has been cloned and vectors incorporating
the cloned DNA have been used to transform Escherichia coli, . . .
Nitta Gelatin obtains United States patent.
Nitta Gelatin, Inc. (Osaka, Japan) has patented a novel process for
culturing animal cells and a kit for culturing animal cells, in which,
even if the number of cells as sampled for biopsy is . . .
Rajavashisth obtains United States patent.
Rajavashisth has patented methods of inhibiting M-CSF activity,
and, in particular, M-CSF/c-fms dependent cell signaling. In a first
embodiment of the invention, one administers to a mammal viral . . .
Bayer CropScience obtains United States patent.
Bayer CropScience GmbH (Frankfurt, Germany) has patented
recombinant nucleic acid molecules which contain two or more nucleotide
sequences which encode enzymes which participate in the . . .
|
|